- Elite Trade Club
- Posts
- Ovarian Cancer Drug Maker Jumps 109%
Ovarian Cancer Drug Maker Jumps 109%
Adam Garcia
March 31, 2025
Presented By
Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
AI (Sponsored)
This daily newsletter cuts through the noise to deliver actionable insights, breaking developments, and practical applications in clear, jargon-free language.
No time for endless research? They distill everything you need to know into a quick, engaging read that fits perfectly into your morning routine.
Their diverse community is leveraging these insights to gain a competitive edge in their fields.
The best part? While others charge premium prices for this level of AI intelligence, Mindstream is completely free.
Markets 📈
Wall Street was mixed on Monday, as investors awaited Trump’s April 2 “liberation day” deadline to introduce more trade tariffs. The S&P 500 returned to positive territory, while the Nasdaq closed with a loss.
|
|
Market-Moving News 📈
Food Delivery
Uber Strengthens Global Reach with New Dining Partnership
Uber (NYSE: UBER) has partnered with OpenTable to merge transportation and dining into a single, streamlined experience across six international markets. The agreement combines Uber's ride-hailing and delivery platforms with OpenTable's restaurant reservation network in the United States, Canada, the United Kingdom, Mexico, Australia, and Ireland.
OpenTable will integrate directly into the Uber and Uber Eats apps, allowing users to book tables and schedule rides through one interface. The partnership aims to simplify how people dine out by pairing reservations with reliable transportation and delivery options.
Developers from both companies have started working on features that will gradually roll out over the coming months. The initiative focuses on user convenience and plans to unlock added value for Uber One members through bundled benefits.
Through platform integration, restaurant partners stand to gain increased exposure, new customer traffic, and opportunities for additional revenue. Uber will help diners discover restaurants and access their reservations more easily, while OpenTable expands access to its reservation system.
Executives confirmed the collaboration will support more than one million restaurant partners worldwide. New tools and updates will appear in phases, enhancing each release's customer and restaurant experience.
Uber officials emphasized the effort as a long-term commitment to improving everyday services. The rollout will begin in key cities and expand based on regional demand and user feedback.
Uranium Market (Sponsored)
On Behalf of Azincourt Energy Corp
A junior miner with high-grade uranium assets in Canada’s Athabasca Basin and Central Mineral Belt is making moves.
Plans are in motion, and the uranium market is heating up.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
Energy Infrastructure
Sempra Sets Course for Growth with Strategic Infrastructure Shift
Sempra (NYSE: SRE) has announced plans to divest specific energy infrastructure assets in Mexico and sell a minority stake in its Sempra Infrastructure unit. The utility company aims to support its $56 billion capital plan over the next five years without relying heavily on future equity issuances.
Executives outlined that the divestment includes Ecogas Mexico, which provides natural gas to over 600,000 customers across three regions. The company also intends to reduce its stake in Sempra Infrastructure, which holds assets in liquefied natural gas, pipelines, and storage facilities.
Headquartered in San Diego, Sempra continues to concentrate its investments on regulated utility operations across California and Texas. The strategy reflects a broader effort to simplify the business and enhance long-term operational efficiency.
Previous stake sales in the infrastructure unit included transactions with global investors such as Kohlberg Kravis Roberts & Co. and the Abu Dhabi Investment Authority. Pending appropriate approvals and market conditions, the latest asset sales are expected to proceed over the next 12 to 18 months.
Leadership confirmed that the shift aligns with Sempra’s infrastructure strategy and long-term utility priorities. The company remains focused on building a more streamlined energy portfolio while maintaining stability across its regulated service areas.
Investor Risk Signals (Sponsored)
Perhaps no one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years.
From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024.
And now, Marc Chaikin is predicting the next crash will start March 14, 2026. If you have money in the markets, Chaikin's thesis is a must-see.
Oil & Gas
Equinor Expands Arctic Operations with Johan Castberg Launch
Equinor (NYSE: EQNR) has officially started production at its Johan Castberg oilfield in Norway’s Barents Sea, marking a major milestone for its Arctic operations. The field adds substantial output capacity and represents Equinor’s second active site in the region.
Operations at Johan Castberg follow years of development setbacks, including weather delays and global supply disruptions. The company expects the site to produce for approximately 30 years, with an estimated 450 to 650 million barrels of recoverable oil.
Production capacity will reach 220,000 barrels per day during the second quarter. Equinor forecasts that the full development cost, valued at over $8 billion, will be recovered within two years of launch.
Plans to expand output through nearby discoveries remain in place. Additional oil reserves may be tied into the floating production, storage, and offloading (FPSO) unit serving the Castberg site.
Ownership of the field includes a 46.3% stake for Equinor, while Vår Energi holds 30%, and Norway’s state-owned Petoro controls the remaining 23.7%.
Norway’s government has promoted increased exploration in the Barents Sea, citing the region’s untapped reserves. Environmental groups continue to raise concerns, especially given the site’s location in sensitive Arctic waters.
The development of the Johan Castberg oilfield supports Equinor’s long-term production strategy and reinforces Norway’s role in global energy supply.
Top Winners and Losers 🔥
Corcept Therapeutics [CORT] $59.59 (+109.08%)
Corcept Therapeutics jumped on Monday after announcing positive results from a late-stage trial of its experimental drug to treat a type of ovarian cancer. The stock price nearly doubled to an ATH above the $100 mark.
Microalgo Inc [MLGO] $24.19 (+39.45%)
Microalgo makes our winners list again after extending gains. The stock has jumped about 900% since the end of March. Today, bulls reacted to WiMi Hologram Cloud’s (NASDAQ: WIMI) move to increase its stake in MLGO to over 67%.
Bluebird Bio [BLUE] $4.88 (+19.61%)
Gene therapy maker Bluebird Bio saw its share price gain traction after announcing on Friday that it had received a non-binding offer from Ayrmid, the parent of cell therapy developer Gamida Cell, for up to $110.5 million.
Vaxcyte Inc [PCVX] $37.76 (-45.64%)
Vaxcyte became the worst performer today after announcing that its experimental pneumococcal vaccine for infants was shown to be at least as effective as Pfizer’s alternative, while investors expected stronger results.
Neurogene Inc [NGNE] $11.71 (-19.35%)
Clinical-stage biotech firm Neurogene fell about 20% amid a general biopharma selloff. The drop came after a top FDA official resigned, citing concerns about the anti-vaccine beliefs of HHS Secretary Robert F. Kennedy Jr. The list of losers is dominated by biotech stocks, including Vaxcyte and Neurogene, which may experience delays in FDA reviews.
Elicio Therapeutics Inc [ELTX] $6.16 (-20.92%)
Elicio Therapeutics is another biotech company hit by the bearish wave. Besides this, the company posted its annual results, reporting a $51.9 million loss, which is nearly 50% higher compared to the previous year.
Uranium Sector (Sponsored)
On Behalf of Azincourt Energy Corp
Ninety percent of America’s uranium is imported. With the US scrambling to rebuild domestic supply, Canadian uranium companies are in prime position.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
*Standard message/carrier rates may apply.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.